GDNF and Parkinson disease: Recently, a randomized, double-blind, placebo-controlled trial focused on the intermittent intraputaminal GDNF administration in patients with motor fluctuating PD was conceived (Whone A. et al., 2019; Whone A. L. et al., 2019).